Inify Laboratories
Olof Sanden is a seasoned executive with extensive experience in leadership roles across various industries, particularly in medical technology and diagnostics. Currently serving as a Partner at TRANSEARCH International since January 2019, Olof is also the Chairman of the Board at Inify Laboratories and ContextVision AB, focusing on innovative solutions in cancer diagnostics and medical image analysis, respectively. Additional board memberships include Unisport Group and Micropos Medical AB, which specialize in sports facility development and precision radiotherapy technologies. Olof's previous roles include Chairman of the Board at ScandiDos and CEO at RISE Research Institutes of Sweden, complemented by senior positions at Bactiguard AB and Elekta. Olof holds a Master of Science in Mechanical Engineering from Chalmers University of Technology and ETH Zürich, along with a Senior Executive Program degree from Columbia Business School.
This person is not in the org chart
This person is not in any teams
Inify Laboratories
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The concept is scalable and can be extended to other diagnoses. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The complete workflow is supported by a tailor-made process control system. The company, based in Sweden, became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications. It is listed on Euronext Growth Oslo under the ticker INIFY.